Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 4/20 | 0.37 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 3/20 | 0.31 |
| ▸ | CHAT | P28329 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17172503 | 0.82 | TYMS (0.41) | TYMSMEN1POLBKMT2A | |
| SCHEMBL15843910 | 0.77 | TYMS (0.50) | TYMSCA12CA2CA9MEN1 | |
| SCHEMBL11947507 | 0.77 | TYMS (0.42) | TYMSCA12CA9MEN1POLB | |
| SCHEMBL31087627 | 0.76 | TYMS (0.43) | TYMSKCNH2MEN1POLBKMT2A | |
| SCHEMBL4256382 | 0.76 | TYMS (0.44) | TYMSCA2CA1MEN1POLB | |
| SCHEMBL14003684 | 0.74 | MAPT (0.49) | TYMSMEN1POLBKMT2A | |
| SCHEMBL11947506 | 0.74 | MAPT (0.49) | TYMSMEN1POLBKMT2A | |
| SCHEMBL17151423 | 0.72 | ANPEP (0.46) | MEN1KMT2A | |
| SCHEMBL28740199 | 0.72 | CA12 (0.44) | TYMSCA12CA2CA9KCNH2 | |
| SCHEMBL17172502 | 0.71 | TYMS (0.53) | TYMSMEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8501046-B2 | Use of rylene derivatives as photosensitizers in solar cells | BASF SE (DE) | 2013-08-06 | — | — | US | disclosed |
| US-20120283432-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | MAX-PLANCK-GESEL. ZUR FOERDERUNG DER WISSEN. E.V. (DE) | 2012-11-08 | — | — | US | disclosed |
| US-8231809-B2 | Solid p-semiconductors may also be used in the inventive dye-sensitized solar cells without increasing the cell resistance, since the rylene derivatives absorb strongly and therefore require only thin n-semiconductor layers | BASF AKTIENGESELLSCHAFT (DE) | 2012-07-31 | — | — | US | disclosed |
| US-20080269482-A1 | Use of Rylene Derivatives as Photosensitizers in Solar Cells | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283432-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | NR2E3, NR2E1, NR1D2 | TYMS 4147/4885CA12 2135/4885CA2 1388/4885 |
| US-20080269482-A1 | Use of Rylene Derivatives as Photosensitizers in Solar Cells | NR2E3, NR2E1, NR1D2 | TYMS 4154/4885CA12 2183/4885CA2 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.